This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
12 - 14 Nov 2024
Hamburg Congress CentreHamburg, Germany



WuXi STA, a subsidiary of WuXi AppTec, is a leading CRDMO providing integrated CMC services including both API and drug product for oligonucleotides, peptides and complex conjugates from discovery to development and commercial manufacturing. We have 12 R&D and manufacturing sites across Asia, North America and Europe.

Our CRDMO platform for oligonucleotides and peptides involves their novel monomers, payloads and linkers, and complex conjugates. Coupled with injectable formulation development and manufacturing services, including Lipid Nano Particle technology (LNP), we enable global partners to accelerate new therapeutics for patients worldwide.

We're bringing you

  • Creating a Comprehensive Toolbox for Oligonucleotide Drug Discovery and Development